@article{ade08cbffbdb4df6939cce20e8073ee2,
title = "Fj{\"o}l{\'o}n{\ae}mir berklar {\'a} {\'I}slandi:: tilfellar{\"o}{\dh} og yfirlit",
abstract = "Inngangur: Fj{\"o}l{\'o}n{\ae}mir berklar eru vaxandivandam{\'a}l {\'i} heiminum. {\'A}rangur me{\dh}fer{\dh}ar erverri, sj{\'u}krah{\'u}slegur lengri og kostna{\dh}ur h{\ae}rri envi{\dh} lyfn{\ae}ma berkla. H{\'e}r er l{\'y}st {\th}remur tilfellumfj{\"o}l{\'o}n{\ae}mra berkla sem greinst hafa {\'a} {\'I}slandis{\'i}{\dh}astli{\dh}in sex {\'a}r, 2003-2008.Sj{\'u}kratilfelli: Fyrsta tilfelli{\dh} var 23 {\'a}ra innflytjandifr{\'a} As{\'i}u sem loki{\dh} haf{\dh}i fyrirbyggjandi me{\dh}fer{\dh}vegna j{\'a}kv{\ae}{\dh}s berklapr{\'o}fs. Tveimur {\'a}rum s{\'i}{\dh}arlag{\dh}ist hann inn me{\dh} berkla {\'i} kvi{\dh}arholi semreyndust vera fj{\"o}l{\'o}n{\ae}mir. Hann lauk 18 m{\'a}na{\dh}ame{\dh}fer{\dh} og l{\ae}kna{\dh}ist. Anna{\dh} tilfelli{\dh} var 23{\'a}ra ma{\dh}ur sem lag{\dh}ist inn vegna fj{\"o}l{\'o}n{\ae}mralungnaberkla. Hann haf{\dh}i {\'a}{\dh}ur fengi{\dh} me{\dh}fer{\dh} {\'i}heimalandi s{\'i}nu {\'i} A-Evr{\'o}pu en ekki loki{\dh} henni.Hann l{\'a} inni {\'i} sj{\"o} m{\'a}nu{\dh}i og n{\'a}{\dh}i bata en gertvar r{\'a}{\dh} fyrir tveggja {\'a}ra me{\dh}fer{\dh}. {\TH}ri{\dh}ja tilfelli{\dh}var 27 {\'a}ra einkennalaus kona sem greindist me{\dh}fj{\"o}l{\'o}n{\ae}ma lungnaberkla vi{\dh} rakningu smits vegnafj{\"o}l{\'o}n{\ae}mra berkla br{\'o}{\dh}ur. Fyrirhugu{\dh} var 18m{\'a}na{\dh}a me{\dh}fer{\dh}.{\'A}lyktun: {\'A} s{\'i}{\dh}ustu sex {\'a}rum greindust {\th}rj{\'u}tilfelli fj{\"o}l{\'o}n{\ae}mra berkla h{\'e}r {\'a} landi sem ern{\'a}l{\ae}gt 5% allra berklatilfella {\'a} t{\'i}mabilinu. {\'A} 12{\'a}rum {\th}ar {\'a} undan greindist eitt tilfelli og g{\ae}ti{\th}etta bent til yfirvofandi fj{\"o}lgunar. Fj{\"o}l{\'o}n{\ae}mirberklar eru alvarlegir, erfi{\dh}ir og kostna{\dh}arsamir{\'i} me{\dh}h{\"o}ndlun. Mikilv{\ae}gt er a{\dh} standa vel a{\dh}berklav{\"o}rnum, s{\'e}rstaklega skimun innflytjenda.Background: Multidrug resistant tuberculosis (MDRTB) is a growing health problem in the world. Treatmentoutcomes are poorer, duration longer and costs higher. Wereport three cases of MDR-TB diagnosed in Iceland in a sixyear period, 2003-8.Case descriptions: The first case was a 23-year-oldimmigrant with a prior history of latent TB infection treatedwith isoniazid. He was admitted two years later withperitoneal MDR-TB. He was treated for 18 months andimproved. The second case was a 23-year-old immigrantdiagnosed with pulmonary MDR-TB after having droppedout of treatment in his country of origin. Clinical andmicrobiological response was achieved and two yearsof treatment were planned. The third case involved a 27-year-old asymptomatic woman diagnosed with MDR-TBon contact tracing, because of her brother{\textquoteright}s MDR-TB. 18months of treatment were planned.Conclusions: Clustering of cases of MDR-TB in the lastsix years, accounting for almost 5% of all Icelandic TBcases in the period, suggests that an increase in incidencemight be seen in Iceland in coming years. The infectionposes a health risk to the patients and the general publicas well as a financial burden on the health care system.Emphasis should be put on rapid diagnosis and correcttreatment, together with appropriate immigration screeningand contact tracing.",
keywords = "MDR, Multidrug resistance, Preventive measures, Treatment, Tuberculosis",
author = "Hilmir {\'A}sgeirsson and Kai Bl{\"o}ndal and {\TH}orsteinn Bl{\"o}ndal and Magn{\'u}s Gottfre{\dh}sson",
year = "2009",
language = "{\'I}slenska",
volume = "95",
pages = "499--507",
journal = "L{\ae}knabla{\dh}i{\dh}",
issn = "0023-7213",
publisher = "Icelandic Medical Association",
number = "7",
}